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Dear Editor,
GBV-C or hepatitis G virus (HGV) was  discovered by two
independent groups of investigators when studying cases
of  hepatitis non-A, non-B, and non-E.1,2 HGV is transmitted
through blood transfusion and components.3,4 Up to now,
there  is no report about detection of GBV-C/HGV RNA by
nucleic  acid test and serological markers in Chinese voluntary
blood  donors. Considering the safety of blood transfusion, we
cooperated with DAAN GENE to evaluate a research diagnos-
tic  kit to screen the GBV-C/HGV RNA. A total of 450 individuals
whose  ALT level was  ≥40 IU/L (mean ± SD: 62.2 ± 25.1 IU/L) and
298  blood donors whose ALT level was  within normal lev-
els  were  enrolled in this study. Age of the donors ranged
from  18 to 57 years (mean ± SD: 30 ± 9 years). All blood donors
had  tested negative for markers of HIV (anti-HIV antibodies),
hepatitis B (HBsAg and anti-HBc antibodies), and hepatitis C
(anti-HCV)  using commercial enzyme immunoassay kits. The
study  sample was  collected at the Beijing Red Cross blood cen-
ter,  Guangzhou blood center, Nanjing Red Cross blood center,
Shanxi  blood center, Deyang blood station, and Suzhou blood
station.
A  Q-PCR research diagnostic kit (DAAN Gene, China)
for  hepatitis G virus was  used to detect GBV-C/HGV RNA.
The  speciﬁc probe targeting the 5′-UTR region was FAM-
ACCGAGCCCGTTACCCACCTG-TAMRA. The speciﬁc primers
for  amplifying the 5′-UTR region of GBV-C/HGV were  as fol-
lows:  forward primer: 5′-ACGTCAGGCTCGTCGTTA-3′; reverse
primer:  5′-TACGTGGGCGTCGTTTG-3′. The plasmids for mak-
ing  standard curve were  qualiﬁed from 107 to 102 copies/mL,
respectively. The Q-PCR procedure was  as follows: reverse
transcriptase at 50 ◦C for 15 min; 95 ◦C for 15 min; one cycle;
94 ◦C for 15 s, 55 ◦C for 45 s, 45 cycles. All Q-PCRs was  per-
formed in Stepone plus system (ABI, USA). The product band
was  recovered and sequenced for ﬁnal determination. The Q-
PCR result indicted that the R2 of standard curve was  0.998.
The  result of NAT showed that GBV-C/HGV RNA was  found
in  1 (0.22%) out of the 450 patients with elevated ALT. The
copy  number of this sample was  1.07 × 105 copies/mL. Fur-
ther  research was  conducted to investigate whether there was
coinfection  in the GBV-C/HGV RNA positive sample with otherviruses. Nucleic acid tests for HAV, HBV, HCV, HEV, and HIV
turned  out negative; likewise, assays to check for HAV-IgG,
HAV-IgM, HEV-IgG, and HEV-IgM antibodies were  all negative.
It  has been reported that 4.3% (12/279) of Chinese paid blood
donors  had GBV-C/HGV RNA detected by RT-PCR.5 In contrast,
only  one HGV-RNA (0.13%) was  detected in 748 samples in this
study. This ﬁnding suggests that the rate of GBV-C/HGV RNA
among  Chinese voluntary blood donors may  be lower than
that  among paid blood donors. To ban paid blood donation
and  advocate voluntary blood donation may  be an effective
way  to control the transmission of HGV. The proportion of HGV
IgG and HGV IgM antibodies in this research was  11% (82/748)
and  10.6% (79/748), respectively. There was no signiﬁcant dif-
ference  in the proportion of HGV-IgG and HGV-IgM antibodies
among  donors with elevated ALT level and those with normal
ALT.  This study indicates that testing for GBV-C/HGV RNA and
serological  markers among Chinese blood donors warrants
further  investigation in the future.
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